Henderson Group
http://www.henderson.comHenderson Group, the holding company for Henderson Global Investors, is a global asset management firm based in London, England. The firm invests in a broad range of asset classes including equities, fixed income, property, and private capital for its institutional, retail and high net-worth clients.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A IDEAYA Biosciences, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Gildan Activewear Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A FLEX LTD. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A AVADEL PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A MADRIGAL PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Akero Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A ZIFF DAVIS, INC. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Liberty Media Corp Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Surgery Partners, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Vaxcyte, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Mirum Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Protara Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A CIMPRESS plc Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Consensus Cloud Solution Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Ascendis Pharma A/S Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Xenon Pharmaceuticals Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Metsera, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Biohaven Ltd. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G APi Group Corp Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Olema Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Verona Pharma plc Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A AMDOCS LTD Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Inspired Entertainment, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
TD Cowen on Janus Henderson Group (JHG): 'Bit Surprised On How The Stock Is Trading'
-
Janus Henderson names Goldman Sachs, Wachtell as advisors for takeover bid
-
Janus Henderson Announces Appointment of Financial Advisor and Legal Counsel to the Special Committee of the Board of Directors
-
Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G ENANTA PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
-
Janus Henderson Group plc (JHG) Tops Q3 EPS by 9c
-
Form 10-Q JANUS HENDERSON GROUP For: Sep 30
-
Janus Henderson Group plc Reports Third Quarter 2025 Results
-
Form 8-K JANUS HENDERSON GROUP For: Oct 30
-
Form 8-K JANUS HENDERSON GROUP For: Oct 27
-
Peltz's Trian, General Catalyst make offer for Janus Henderson valuing it at $7.2 billion
-
Janus Henderson receives $46 per share acquisition proposal from Trian, General Catalyst
-
Janus Henderson Group plc Confirms Acquisition Proposal from Trian and General Catalyst
-
Form SCHEDULE 13D/A JANUS HENDERSON GROUP Filed by: TRIAN FUND MANAGEMENT, L.P.
-
Libertas Secures $100 Million Credit Facility From Victory Park Capital to Help Small to Medium-Sized Businesses Accelerate Growth
-
Form SCHEDULE 13G/A 89bio, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Janus Henderson to Report Third Quarter 2025 Results

